GeneDx Holdings (WGSWW) Other Non-Current Liabilities (2020 - 2026)

GeneDx Holdings has disclosed Other Non-Current Liabilities across 7 years of filings, most recently posting $71000.0 for Q1 2026.

• In Q1 2026, Other Non-Current Liabilities fell 98.93% year-over-year to $71000.0; the TTM figure through Mar 2026 stood at $71000.0 (down 98.93% YoY), while the FY2025 annual figure was $1.6 million, down 70.27% from the prior year.
• Other Non-Current Liabilities declined to $71000.0 in Q1 2026, from $1.6 million in the prior quarter.
• Over the last five years, Other Non-Current Liabilities for WGSWW reached as high as $24.0 million in Q4 2022 and fell as low as $71000.0 in Q1 2026.
• The 5-year median for Other Non-Current Liabilities is $6.6 million (2025), against an average of $9.8 million.
• Annual changes were most pronounced in 2024 — Other Non-Current Liabilities surged 5654.55% — and 2026, when it tumbled 98.93%.
• A 5-year view of Other Non-Current Liabilities shows it stood at $24.0 million in 2022, then slumped by 38.65% to $14.7 million in 2023, then plunged by 62.54% to $5.5 million in 2024, then sank by 70.27% to $1.6 million in 2025, then plunged by 95.67% to $71000.0 in 2026.
• According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $71000.0, $1.6 million, and $4.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.